![Collegium Pharmaceutical](https://dev.collegiumpharma.com/wp-content/uploads/logo.svg"){kind=logo}
leading with science
Empowering people living with serious medical conditions and healthcare professionals
We lead with science to provide consistent support to people living with serious medical conditions and the healthcare professionals treating them. Our dedication to following the science ensures that our portfolio contains effective treatment options for people living with serious medical conditions and supports the healthcare providers treating them.
Our highly experienced team cares deeply about “doing right” by our patient and medical communities, and we are dedicated to empowering their decision making through science-based, educational resources.
Collegium is committed to supporting high quality educational programs through medical education grants. For information on Collegium’s Educational Grant Program, please contact us at EducationalGrantReviewCommittee@collegiumpharma.com.
our portfolio
Building a leading, diversified specialty pharmaceutical company
Collegium is focused on delivering approved medicines with potential to improve the lives of people living with serious medical conditions, including severe and persistent pain and attention deficit hyperactivity disorder (ADHD).
Our portfolio of clinically differentiated medicines includes internally developed and more recently acquired products, each of which represents meaningful innovation.
We believe in the importance of our products for people living with serious medical conditions, and the far-reaching impact they can make to help many people live healthier lives.